Metrics as of 10/16/2026, 08:33 AM (Berlin time), refresh in progress.
Johnson & Johnson Stock
Johnson & Johnson
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- United States
- CEO
- Joaquin Duato
- Employees
- 140,800
- Market cap
- $800.9 B
- IPO
- 22/12/2025
- Web
- www.jnj.com
Johnson & Johnson is a holding company headquartered in New Brunswick, US, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company operates through two primary segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience,…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Johnson & Johnson stock: price history
1D
-0.2%
1W
+1.7%
1M
-1.3%
6M
+13.8%
YTD
+28.4%
1Y
–
2Y
–
5Y
–
10Y
–
Ask the agents about Johnson & Johnson
Free float & liquidity
FREE FLOAT
–
FLOAT SHARES
–
AVG. DAILY VOLUME (30D)
10,264
Dividends
Comparable stocks
Frequently asked questions about Johnson & Johnson stock
What does Johnson & Johnson do?
Johnson & Johnson is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in United States.
The CEO is Joaquin Duato, the company employs around 140,800 people.
The IPO was on 22/12/2025; the stock trades on TSX under the ticker JNJ.TO.
Does Johnson & Johnson pay a dividend?
Yes. The last dividend was CA$0.17 per share, ex-date 25/08/2026, paid on 15/09/2026.
Which stocks are comparable to Johnson & Johnson?
Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Amgen, Gilead Sciences, Pfizer and Bristol-Myers Squibb Company.
How can I get Johnson & Johnson stock analyzed?
Clicking "Analyze stock" lets five strategies assess Johnson & Johnson against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.